Acriflavine, a clinically aproved drug, inhibits SARS-CoV-2 coronavirus and other betacoronaviruses

Coronavirus, Health, Treatment

We show that acriflavine inhibits viral replication at nanomolar concentration in cellular models, in vivo in mice and ex vivo in human airway epithelia, with broad range activity against SARS-CoV-2 and other betacoronaviruses.

Full preprint




** This post was originally published on March 22, 2021 **